Scarica l'app Stockscreener
4.76
4.03%
-0.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHC Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bausch Health Companies Inc Borsa (BHC) Ultime notizie
Actinic Keratosis Market to Witness Transformational Growth Opportunities by 2036 – DelveInsight | Almirall, Biofrontera Pharma, Vidac Pharma, Rubedo Life Sciences, Bausch Health, Sandoz Pharma - Barchart.com
TSX Healthcare Stocks: Which Names Are Drawing Market Attention? - Kalkine Media
BHC Q1 2026 Earnings: EPS Surges 12.33% Above Estimates, Shares Edge HigherEarnings Surprise Score - newsline.com
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia - Cantech Letter
Why Bausch Health Companies Inc stock is sliding today - Wealth Awesome
Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7 - Moomoo
Is Bausch Health Finally Finding Its Comeback Moment? - Kalkine Media
Bausch Health: Invest In The Short-Term Bonds, Not The Stock (NYSE:BHC) - Seeking Alpha
Valeant Investors Should Get Cert. In PwC Fight, Report Says - Law360
Bausch Health Companies stock (CA0717341071): Canadian pharma name in focus after fresh institutiona - AD HOC NEWS
Bausch (BHC) Down 5.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Only 217 brands in China hold this mark. Thermage just earned it - Stock Titan
Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China - PR Newswire
TSX Pharma Companies Building Regional Healthcare Reach - Kalkine Media
Bausch Health (BHC) director Amy Wechsler granted $250,000 in RSUs - Stock Titan
Bausch Health (NYSE: BHC) grants $250,000 RSU award to director Eiry Roberts - Stock Titan
Bausch Health (NYSE: BHC) director receives $250,000 RSU equity grant - Stock Titan
John Paulson (BHC) receives $250K RSU award and reports large fund holdings - Stock Titan
Bausch Health (BHC) director awarded $250K in RSUs - Stock Titan
Bausch Health (BHC) director awarded $250K in restricted share units - Stock Titan
Bausch Health (BHC) director Sarah Kavanagh receives $250,000 RSU grant - Stock Titan
Bausch Health (NYSE: BHC) director awarded 45,871 RSUs valued at $250,000 - Stock Titan
Director Garcia (BHC) receives $250,000 restricted share grant in Form 4 - Stock Titan
BHC Q1 2026 Earnings: EPS Surprises to the Upside Amidst Operational ExecutionGuidance Downgrade Alert - newsline.com
Bausch Health Cos (BHC) Stock Price, News & Analysis $BHC - MarketBeat
Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading PlayersDompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals - Yahoo Finance
Bausch Health (NYSE: BHC) director sells 24,456 shares under plan - Stock Titan
New Bausch Health (BHC) director Eiry Roberts added as insider on Form 3 - Stock Titan
BHC: Sustained growth, China expansion, and BLCO monetization drive strategic priorities - TradingView
Bausch Health shareholders elect board members and approve auditor at annual meeting By Investing.com - Investing.com South Africa
Bausch Health shareholders elect board members and approve auditor at annual meeting - Investing.com
Shareholders of Bausch Health (NYSE: BHC) approve directors, pay and PwC - Stock Titan
Eiry Roberts to chair Bausch Health science and technology committee - Stock Titan
[144] Bausch Health Companies Inc. SEC Filing - Stock Titan
Bausch + Lomb launches PreserVision AREDS3 eye vitamins in U.S. By Investing.com - Investing.com Australia
Bausch + Lomb launches PreserVision AREDS3 eye vitamins in U.S. - Investing.com UK
Cannabis Pharmaceuticals Business Research Report 2026: An - GlobeNewswire
Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth - Yahoo Finance
Bausch Health rises on Q1 double beat, 2026 guidance - MSN
Bausch Health Companies (BHC) price target decreased by 10.52% to 6.72 - MSN
Dry Eye Products Market Will Generate Booming Growth - openPR.com
BHC Stock Price, Quote & Chart | BAUSCH HEALTH COS INC (NYSE:BHC) - ChartMill
Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference - The Globe and Mail
Hear Bausch Health chiefs in live RBC healthcare chat May 20 - Stock Titan
Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference - 富途牛牛
Why BauschHealth (BHC) might be the steady performer you need (Technical Weakness) 2026-05-11IV Crush Alert - newsline.com
Bausch Health's Q1 Total Prescriptions Hurt by Exit From Federal Drug Pricing Programs, RBC Says - Moomoo
Bausch Health Cos (BHC) Earnings Date and Reports 2026 $BHC - MarketBeat
Bausch Health to redeem ~$602M of outstanding notes due 2026 - MSN
Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe – Company Announcement - Financial Times
Bausch Health: Strong Margins, Weak Volumes, Equity Story Hinges On Deleveraging - Seeking Alpha
How many employees work at Solta Medical? - Revelio Labs
Bausch Health (BHC) Q1 2026 Earnings Transcript - AOL.com
Bausch Health Companies Inc. (NYSE:BHC) Q1 2026 Earnings Call Transcript - Insider Monkey
MSN Money - MSN
0.95%
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):